Pharmacopia Labs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2022
- Revenue Growth %
- Profit Growth -51.16%
- Ebitda -55.17%
- Net Worth -27.19%
- Total Assets 602.06%
About Pharmacopia Labs
Pharmacopia Labs Private Limited (PLPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 July 2015 (Nine years and six months 24 days old ). Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Evantari Labs Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Naveen Puttagunta and Aslam Khan serve as directors at the Company.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U72300TG2015PTC099757
-
Company No.
099757
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 Jul 2015
-
Date of AGM
30 Sep 2022
-
Date of Balance Sheet
31 Mar 2022
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Pharmacopia Labs?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Naveen Puttagunta
|
Director | 10-Jul-2015 | Current |
|
Aslam Khan
|
Director | 10-Jul-2015 | Current |
Financial Performance of Pharmacopia Labs.
Pharmacopia Labs Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 51.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 27.19%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharmacopia Labs?
In 2018, Pharmacopia Labs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Allure Aesthetics And Skin Care Private LimitedAslam Khan is a mutual person
-
Divami Design Labs Private LimitedNaveen Puttagunta is a mutual person
-
Dera Televisions Private LimitedAslam Khan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharmacopia Labs?
Unlock and access historical data on people associated with Pharmacopia Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharmacopia Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharmacopia Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
